T-Mobile blasts allegations of coverage fraud

first_img Amazon reels in MGM T-Mobile US hit back against accusations by the Rural Wireless Association (RWA) that it exaggerated its coverage area in data submitted to the Federal Communication Commission (FCC) as part of a major funding programme.In a recent filing to the commission, T-Mobile said RWA’s claims were unfounded and “patently false”. The operator noted it had “not been contacted by the commission” regarding an investigation into alleged violation of LTE coverage statement requirements and had “no reason to believe” it is involved.The operator went on to argue that it actually underrepresented its coverage reach in its reports: “Contrary to RWA’s claim that T-Mobile submitted future coverage, T-Mobile followed required procedures and submitted shapefiles reflecting 4G LTE coverage as of December 2017…Rather than overstating T-Mobile coverage, the submitted files more likely understate coverage as T-Mobile continued to expand its network throughout the challenge process.”Earlier this month, the FCC suspended its Mobility Fund Phase II proceeding, a federal funding programme set to distribute $4.53 billion to expand LTE to underserved areas, after a review of coverage data submitted by operators suggested violations of its reporting rules.While the FCC did not detail the nature of the violations or which operators were involved, the suspension came shortly after members of the RWA met with the commission to air concerns that Verizon and T-Mobile had overstated coverage.The RWA asked the commission to investigate and bar operators which filed “overstated coverage, projected coverage, or false coverage” from receiving funds. Subscribe to our daily newsletter Back AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 20 DEC 2018 Deutsche Telekom, SoftBank tipped for T-Mobile trade Related T-Mobile US chief predicts market rebound Home T-Mobile blasts allegations of coverage fraud Diana Goovaerts Author Diana is Mobile World Live’s US Editor, reporting on infrastructure and spectrum rollouts, regulatory issues, and other carrier news from the US market. Diana came to GSMA from her former role as Editor of Wireless Week and CED Magazine, digital-only… Read more Previous ArticleHong Kong raises $767M in spectrum auctionNext ArticleBlog: Huawei deserves credit for tackling security claims head-on Tags 4G coverageFederal Communications Commission (FCC)T-Mobile USlast_img read more

Read More

CDC notes Shigella strains with reduced susceptibility

first_imgThe Centers for Disease Control and Prevention (CDC) is warning clinicians and public health officials of emerging strains of Shigella bacteria with reduced susceptibility to ciprofloxacin, one of the main antibiotics used to treat shigellosis.In a health advisory issued yesterday, the CDC said it has identified an increase in Shigella isolates in the United States with minimum inhibitory concentration (MIC) values of 0.12 to 1.0 microgram per milliliter (mcg/mL) for ciprofloxacin, a fluoroquinolone antibiotic, and that preliminary data suggest that all Shigella isolates with ciprofloxacin MICs in this range harbor at least one quinolone resistance gene. Shigella isolates without a quinolone resistance gene typically have a ciprofloxacin MIC of 0.015 (mcg/mL) or less, the CDC says.MIC values are used to determine the resistance of an organism to an antimicrobial agent. Antibiotics with lower MIC scores are considered more effective, because the lower MIC value means less of the drug is required to inhibit growth of the organism. Clinicians in turn use MIC values as a guide for choosing which antibiotic to use to treat an infection. But the advisory notes that under the current interpretive criteria of the Clinical and Laboratory Standards Institute (CLSI), Shigella isolates with a ciprofloxacin MIC of 1.0 (mcg/mL) or less are considered susceptible to ciprofloxacin.While the agency does not yet know whether using fluoroquinolones to treat a Shigella infection with a ciprofloxacin MIC of 0.12 to 1.0 mcg/mL is associated with worse outcomes or increases the risk of transmission, it’s recommending that clinicians consider other antibiotics out of concern that fluoroquinolone treatment may be less effective and may increase the risk of secondary cases.”Clinicians treating patients with multidrug-resistant shigellosis for whom antibiotic treatment is indicated should avoid prescribing fluoroquinolones if the ciprofloxacin MIC is 0.12 mcg/mL or higher even if the laboratory report identifies the isolate as susceptible, and should work closely with their clinical microbiology laboratory and infectious disease specialists to determine appropriate antimicrobial therapy,” the CDC advised.Growing resistanceShigella bacteria, mainly S sonnei and S flexneri, cause about 500,000 cases of diarrhea in the United States each year and are highly contagious. Exposure to even the smallest amount of contaminated fecal matter can cause illness. Shigella infection most commonly occurs from eating food contaminated by people who have shigellosis, but it is also associated with travel to disease-endemic areas, crowding, poverty, and attendance at daycare centers.While diarrhea caused by Shigella usually resolves without the need for antibiotics, antibiotic treatment can shorten the duration of symptoms in more severe cases. Yet antibiotic resistance in Shigella is a growing problem, with resistance to traditional first-line antibiotics like ampicillin and trimethoprim-sulfamethoxazole now common and resistance to azithromycin and ciprofloxacin—the two drugs most commonly used to treat shigellosis—on the rise.The CDC, which declared antibiotic-resistant Shigella an urgent threat in the United States in 2013, estimates that 27,000 US Shigella infections annually are resistant to one or both of these antibiotics.In its health advisory, the CDC said rising resistance to fluoroquinolones in Shigella isolates could be related to the emergence of plasmid-mediated quinolone resistance (PMQR) genes in Shigella species in the United States. PMQR genes are a concern because of their ability to spread fluoroquinolone resistance to Shigella bacteria that have never been exposed to the drugs; they can also spread resistance to other types of bacteria. While high prevalence of PMQR genes in Shigella bacteria has been reported in countries such as China and India, prevalence in US Shigella is currently unknown, the CDC said.Guidance for clinicians, health officialsThe agency recommends that clinicians order stool culture for patients suspected of having a Shigella infection, and order antimicrobial susceptibility testing for isolates. In patients for whom antibiotic treatment is indicated, clinicians are advised to use the susceptibility testing results to guide antibiotic choice, with special attention given to MIC values for fluoroquinolone antibiotics.   Because shigellosis is a nationally notifiable condition, all cases have to be reported to local health department. The CDC says clinicians should include the identification of isolates with a MIC value of 0.12 mcg/mL or higher in their reports. In addition, public health officials are urged to submit those isolates to the state public health laboratory for whole-genome sequencing, which can identify quinolone resistance genes.The CDC says it will continue to monitor trends in antimicrobial susceptibility of Shigella isolates. The agency added that it is working with clinical and public health partners to determine if ciprofloxacin is associated with worse outcomes in patients infected with Shigella strains carrying quinolone resistance genes.See also:Apr 18 CDC health advisorylast_img read more

Read More

Visiocorp Names Global Account Director, North America

first_imgWith more than 20 years of experience across multiple industries and functional areas, deMoulpied has particular expertise in organizations with complex technical products. Combined, his prior positions have required a spectrum of skills in corporate strategy, operations improvement, product quality, and revenue cycle management. He has an impressive history of utilizing data driven problem solving (Lean Six Sigma) and project management (PMP and CSM) to achieve strategic goals surrounding customer satisfaction, operational efficiency and improved profit.  DeMoulpied has a Bachelor of Science degree in Engineering Management from the United States Air Force Academy and a Master of Business Administration degree from the University of Dayton in Marketing and International Business. He served six years with the USAF overseeing the development of technology used on fighter aircraft and the E-3 Surveillance aircraft, finishing his career honorably as Captain. MARYSVILLE, MI — Visiocorp USA, Inc., a manufacturer of car and light truck mirrors, has announced that Jeff McQueen has joined the company’s Detroit sales office as the global account director – North America, with global responsibility for the commercial business of Chrysler, Ford and General Motors. He is the local contact for all sales activities in North America, and will partner with other Visiocorp global account directors around the world for business development. He was previously North American director of sales at REHAU, Inc. AdvertisementClick Here to Read MoreAdvertisement McQueen will assist in supporting the North American commercial activities for Visiocorp’s key account managers who are responsible for the Korean, Japanese and European accounts based in North America. McQueen is the fourth generation of his family to work in the global automotive industry. He has a bachelor of arts from Kalamazoo College and an MBA from Michigan State University. McQueen also speaks several languages including German, French, Japanese and Spanish, and has lived in Europe and Asia. He joined Visiocorp in November 2007. For more information about Visiocorp, go to: www.visiocorp.com.,Lubrication Specialties Inc. (LSI), manufacturer of Hot Shot’s Secret brand of performance additives and oils, recently announced the expansion of senior leadership. Steve deMoulpied joins LSI as the company’s chief operating officer (COO). AdvertisementClick Here to Read MoreAdvertisement DeMoulpied comes to LSI from the Private Client Services practice of Ernst & Young where he managed strategy & operations improvement engagements for privately held client businesses. Some of his prior roles include VP of strategic development, director of strategic initiatives, and Lean Six Sigma Master Black Belt at OptumHealth, UnitedHealth Group’s health services business, as well as Lean Six Sigma Black Belt at General Electric, where he applied operations improvement principles to customer service, supply chain and product development. A successful entrepreneur, deMoulpied is also the founder of PrestoFresh, a Cleveland-based e-commerce food/grocery business.  LSI President Brett Tennar says, “Steve’s success in developing operational strategies that improves the bottom line, builds teamwork, reduces waste and ensures quality product development and distribution checks many of the boxes of what we were looking for in a COO. This, coupled with his career in the Air Force working with highly technical systems and his in-depth understanding of Lean Six Sigma and Business Process Management sealed our offer. As our tagline states, our products are Powered by Science. This data driven approach is one reason why our company has grown exponentially as we employ the most advanced technology to product development. I am confident that Steve is the right person to drive operational strategy for our diverse and growing brands.” Advertisementlast_img read more

Read More

Bruce Arians says only coaching job he’d take is with Browns

first_img“Cleveland is the only job I would consider,” he said while in the CBS booth Sunday, via Cantonrep.com.Arians previously coached for the Browns as the offensive coordinator (2001–03) under Butch Davis. It was a time when the Browns had a winning record, with the team going to the playoffs in 2002. Related News Arians spent 2013-17 with Cardinals, and after the 2017 season he announced his retirement.As for who he would hire on his Browns staff, Arians named his former mentor.“My guy would be Chuck Pagano,” Arians said. Bruce Arians revealed only one coaching job could bring him out of retirement.The former Cardinals coach said only being offered the Browns’ head coach position would make him get back on the sidelines. Since then, Cleveland has gone through quarterbacks and coaches at an alarming rate. According to Arians, the team needs an experienced coach.Arians does have experience. He was hired at the end of the 2003 season to work with the Steelers and was promoted to offensive coordinator in 2007. He held on to that position until 2011.He then went to work under Chuck Pagano with the Colts in 2012, where he had his first NFL head coaching stint as interim coach when Pagano was diagnosed with Leukemia early in the season.He led the Colts to a 9-3 record and earned 2012 AP Coach of the Year honors, making him the first interim head coach to win the award.When the Browns were looking for a new head coach in 2013, Arians wanted to be their guy. But Cleveland hired Rob Chudzinski instead. Is recently fired Hue Jackson the worst coach in NFL history? According to statistics …last_img read more

Read More